Overview
- UK Biobank has officially cleared Chinese researchers, including a unit from BGI, to access anonymised NHS GP records under strict security protocols.
- China accounts for nearly 20% of approved applications for access to UK Biobank data, second only to the United States.
- The decision follows extensive audits by NHS England, which confirmed compliance with data protection and security requirements for international access.
- MI5 has previously raised concerns about the potential misuse of health data by authoritarian regimes, highlighting risks of genetic surveillance and espionage.
- UK Biobank emphasizes that all data shared is anonymised and access is granted only to legitimate researchers, with no evidence of individuals being identified to date.